December 13, 2022

HealthDay News informs the public of the 12-year TAILORx results

December 13, 2022

Blinatumomab regimen may lead to ā€˜diminishing use of transplantā€™ for B-ALL subgroup (study E1910)

October 13, 2022

The September/October 2022 News from ECOG-ACRIN blog is now available

October 4, 2022

DREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma

September 30, 2022

Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy

September 28, 2022

Immunotherapy before targeted therapy improves survival in advanced melanoma, according to the DREAMseq trial

September 26, 2022

The Fall 2022 advocacy blog Considering Clinical Trials is now available

August 16, 2022

The August 2022 News from ECOG-ACRIN blog is now available

August 10, 2022

President Biden announces his intent to appoint Dr. Monica Bertagnolli as the next NCI director

ECOG-ACRIN Cancer Research Group